SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Sales of Investments

Cash received from selling or redeeming investments.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments of $3.01M in Q1 FY2026

Q1 FY2026 sales of investments was $3.01M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.01M-49.8% QoQ
Last fiscal yearDec 2025
$6M— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
6M USD
Year-over-year change
—

Sales of Investments vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Sales of Investments for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$314.34M USD+33.1%+37.0%4127.9%
RXSTRxSight, Inc.LTM Mar 2026$310M USD+35.4%+0.6%243.2%
GKOSGlaukos CorporationLTM Jun 2026$185.16M USD-22.8%+13.4%30.2%
STAASTAAR Surgical CompanyLTM Apr 2026$83.12M USD+11.5%+93.8%28.6%
BLCOBausch + Lomb CorporationLTM Jun 2026$7.92M USD-32.6%-28.6%0.1%
ALCAlcon Inc.LTM Sep 2026$7M USD-95.3%+24.9%0.1%
SGPSpyGlass Pharma, Inc. Common StockFY2025$6M USD———
OCULOcular Therapeutix, Inc.LTM Mar 2026$0 USD——0.0%
SGHTSight Sciences, Inc.LTM Mar 2026$0 USD——0.0%
OCSOculis Holding AGLTM Mar 2026CHF 0 CHF——0.0%
Peer median (excluding SGP) —-5.6%+19.2%0.1%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.